Modulation of Individual Susceptibility to the No-Reflow Phenomenon after Acute Myocardial Infarction

E-ISSN： 1873-4286|19|25|4519-4528

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.25, 2013-08, pp. : 4519-4528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No-Reflow: A Heterogeneous Clinical Phenomenon with Multiple Therapeutic Strategies

Current Pharmaceutical Design, Vol. 12, Iss. 29, 2006-10 ,pp. : 3807-3815

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Statins on the No-Reflow Phenomenon: An Observational Study in Patients with Hyperglycemia before Primary Angioplasty

By Zhao Jing-Lin Yang Yue-Jin Pei Wei-Dong Sun Yu-Hua Chen Ji-Lin

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 2, 2009-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Alcohol and Acute Myocardial Infarction

By Biyik I Ergene O

The Journal of International Medical Research, Vol. 35, Iss. 1, 2007-01 ,pp. : 46-51

Field House Publishing

Access to resources Recommend Favorite

Evidence-Based Treatments and Prescription Variability after Acute Myocardial Infarction

By Bobbio M. Imazio M. Tidu M.

Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. : 241-250

Adis International

Access to resources Recommend Favorite

ACE inhibitors or AT-1 antagonists – which is OPTIMAAL after acute myocardial infarction?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 407-409

Informa Healthcare

Access to resources Recommend Favorite